Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/8/2021
CDE on the Guidelines for Writing Relevant Pediatric Use Information i...
9/8/2021
CDE Solicits Public Comments on the Technical Guidance on Clinical Pro...
9/8/2021
Sandoz and Bio-Thera Reach China Oncology Biosimilar Deal
9/8/2021
Hutchmed, AstraZeneca Launches Orpathys + Tagrisso Combo Trial for Lun...
9/8/2021
Frontage Expands Early Drug Discovery Services through the Acquisition...
9/7/2021
AffaMed Enters into Strategic Partnership with BJ Tiantan Hospital and...
9/7/2021
Ascletis's Gannex Granted Chinese Clinical Trial Approval of FXR Agon...
9/7/2021
Sinopharm to Develop Second-Generation mRNA COVID-19 Vaccine
9/7/2021
Bayer, BJ Branch of CMA Sign Deal to Boost Innovation
9/7/2021
NMPA Announces Package Insert Revision of Diammonium Glycyrrhizinate F...
9/7/2021
NMPA Announces Package Insert Revision of Azlocillin Sodium for Inject...
9/7/2021
MSD's KEYTRUDA Approved in China in Combo with Chemotherapy for First-...
9/7/2021
GlobalData: China Leads Biosimilar Development and Marketing in APAC
9/7/2021
Innovent and GenFleet Enter Global License Deal for GFH925 (KRAS G12C ...
9/7/2021
Move over, Shanghai and Beijing? Suzhou wants to be the 'Pharmacy Vall...
9/6/2021
NHSA Unveils the Draft Interim Regulations for Medical Insurance Inspe...
9/3/2021
CDE Solicits Comments on the Technical Guidance on Clinical Trial of A...
9/3/2021
CDE Solicits Comments on the Technical Guidance on Data Management and...
9/3/2021
CDE Solicits Comments on the Technical Guidance on Application of Pati...
9/3/2021
NHC Issues the Working Procedures for Adjustment of the List of Drugs ...
9/3/2021
JW Therapeutics Granted Chinese Approval of T-Cell Therapy for Large B...
9/3/2021
Innovent and GenFleet Ink Deal for KRAS Inhibitor
9/3/2021
Arctic Vision Obtains China IND Clearance for PIII Study of ARVN003, F...
9/3/2021
Inventiveness of Chinese Second Medical Use Patent: A Study From Top 1...
9/3/2021
Wyeth Secured Win With Punitive Damages But Courts Had Different Opini...
9/3/2021
Investment Prospects in China's Biopharmaceuticals and Biomaterials In...
9/3/2021
Healthcare Sector Could Be the Next Target of Chinese Regulatory Crack...
9/1/2021
What Are China's Pharma Prospects as the Country Enters Another New No...
9/1/2021
NMPA Announces Package Insert Revision of Creatine Phosphate Sodium fo...
9/1/2021
CDE Seeks Comments on Implementation Advice on ICH Guidelines E18, M3(...
Page:
115
/
719
Total number of articles:
21549
:
[First]
[<<]
[113]
[114]
[115]
[116]
[117]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit